Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
67.83
0.00
(0.00%)
As of March 3 at 11:00:07 AM GMT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 18 | 20 |
| Avg. Estimate | 11.24B | 12.57B | 47.95B | 50.33B |
| Low Estimate | 11.02B | 12.37B | 47.56B | 49.54B |
| High Estimate | 11.59B | 12.73B | 48.56B | 51.64B |
| Year Ago Sales | 11.23B | 12.31B | 46.9B | 47.95B |
| Sales Growth (year/est) | 0.08% | 2.09% | 2.24% | 4.98% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CCC3D.XC | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 2/28/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/13/2025 |
| Maintains | UBS: Buy to Buy | 2/12/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/12/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/12/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/12/2025 |